Integrated 2

Alphabetical Test listing

Integrated 2-13496

  
Integrated 2
  
13496
  
LAB13496
  
INT2
  
AFP-maternal
Down syndrome
  

Screening test for open neural tube defects, Down syndrome and trisomy 18.

  
Serum
  
  
5 mL
  
3.0 mL
  
  • Collect 2nd draw between 15wks 0dys and 21wks 6dys (15.0 - 21.9 weeks)

  • Maternal serum specimens must be drawn prior to amniocentesis to avoid contamination with fetal blood
  

Spin; pour off/aliquoting is not advised

  

Gold serum separator (SST) tube

  
  • Patient must have submitted a previous specimen in the first trimester for the Integrated 1 test.
    • Gestational age will be based on crown rump length provided with the first trimester specimen.
  • Patient’s most recent weight
  • Maternal testing clinical information form
  

Ambient (preferred) - 7 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x 3

  
  • Gross hemolysis
  • Gross lipemia
  • Quantity not sufficient for analysis (QNS) 
  • Improper specimen type
  
LabCorp RTP (017170): R-LC
  
Mo - Sa
  
2 - 5 days
  

Chemiluminescent immunoassay

  

An interpretive report will be provided

  

There is no risk assessment after the first draw. A specimen for the Integrated 2 must be collected and the overall risks for Down syndrome, trisomy 18 and open spina bifida are provided after the testing of the second blood sample, using information from the part 1 and part 2.

 

  
86336
84702
82105
82677
  
Result 49586-1
  
04/09/2019
  
03/04/2021
  
03/02/2021